Pancreatic polypeptide in obese children before and after weight loss

International Journal of Obesity

Volumn 30, Issue 10, 2006, Pages 1476-1481

  Reinehr, T ^a   Enriori, P J ^b   Harz, K ^c   Cowley, M A ^b   Roth, C L ^c  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Children; Insulin; Leptin; PP; Weight loss

Indexed keywords

PANCREAS POLYPEPTIDE;

AGE DISTRIBUTION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVELOPMENTAL STAGE; DIET RESTRICTION; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SEX DIFFERENCE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY MASS INDEX; CHILD; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; OBESITY; PANCREATIC POLYPEPTIDE; PUBERTY; WEIGHT LOSS;

EID: 33749133822     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803393     Document Type: Article

References (41)

1. Wynne K, Stanley S, McGowan B, Bloom S. Appetite control. J Endocrinol 2005; 184: 291-318.
2. Wynne K, Stanley S, Bloom S. The gut and regulation of body weight. J Clin Endocrinol Metab 2004; 89: 2576-2582.
3. Murphy KG, Bloom SR. Gut hormones in the control of appetite. Exp Physiol 2004; 89: 507-516.
4. Small CJ, Bloom SR. Gut hormones and the control of appetite. Trends Endocrinol Metab 2004; 15: 259-263.
5. Schwartz TW. Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 1983; 85: 1411-1425.
6. Weyer C, Salbe AD, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. Exaggerated pancreatic polypeptide secretion in Pima Indians: can an increased parasympathetic drive to the pancreas contribute to hyperinsulinemia, obesity, and diabetes in humans? Metabolism 2001; 50: 223-230.
7. Vozarova de Courten B, Weyer C, Stefan N, Horton M, DelParigi A, Havel P et al. Parasympathetic blockade attenuates augmented pancreatic polypeptide but not insulin secretion in Pima Indians. Diabetes 2004; 53: 663-671.
8. Katsuura G, Asakawa A, Inui A. Roles of pancreatic polypeptide in regulation of food intake. Peptides 2002; 23: 323-329.
9. Asawaka A, Inui A, Ueno N, Fujino MA, Kasuga M. Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice. Peptide 1999; 20: 1445-1448.
10. Gettys TW, Garcia R, Savage K, Whitcomb DC, Kanayama S, Taylor IL. Insulin-sparing effects of pancreatic polypeptide in congenitally obese rodents. Pancreas 1991; 6: 46-53.
11. Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003; 124: 1325-1336.
12. Ueno N, Inui A, Iwamoto M, Kaga T, Asakawa A, Okita M et al. Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology 1999; 117: 1427-1432.
13. Brunicardi FC, Chaiken RL, Ryan AS, Seymour NE, Hoffmann JA, Lebovitz HE et al. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab 1996; 81: 3566-3572.
14. Batterham RL, Le Roux CW, Cohen MA, Park A, Ellis SM, Patterson M et al. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 2003; 88: 3989-3992.
15. Hazelwood RL. The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behavorial implications. Proc Soc Exp Biol Med 1993; 202: 44-63.
16. Wisen O, Bjorvell H, Cantor P, Johansson C, Theodorsson E. Plasma concentrations of regulatory peptides in obesity following modified sham feeding (MSF) and a liquid test meal. Regul Pept 1992; 39: 43-54.
17. Pieramico O, Malfertheiner P, Nelson DK, Glasbrenner B, Ditschuneit H. Interdigestive cycling and post-prandial release of pancreatic polypeptide in severe obesity. Int J Obes Relat Metab Disord 1990; 14: 1005-1011.
18. Meryn S, Stein D, Straus EW. Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation. Int J Obes Relat Metab Disord 1986; 10: 37-42.
19. Lassmann V, Vague P, Vialettes B, Simon MC. Low plasma levels of pancreatic polypeptide in obesity. Diabetes 1980; 29: 428-430.
20. Glaser B, Zoghlin G, Pienta K, Vinik AI. Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance. Horm Metab Res 1988; 20: 288-292.
21. Marco J, Zulueta MA, Correas I, Villanueva ML. Reduced pancreatic polypeptide secretion in obese subjects. J Clin Endocrinol Metab 1980; 50: 744-747.
22. Meryn S, Stein D, Straus EW. Fasting- and meal-stimulated peptide hormone concentrations before and after gastric surgery for morbid obesity. Metabolism 1986; 35: 798-802.
23. Schrumpf E, Linnestad P, Nygaard K, Giercksky KE, Fausa O. Pancreatic polypeptide secretion before and after gastric bypass surgery for morbid obesity. Scand J Gastroenterol 1981; 16: 1009-1014.
24. Miskowiak J, Andersen B, Stadil F, Fahrenkrug J. Meal stimulated levels of pancreatic polypeptide (PP) and vasoactive intestinal polypeptide (VIP) in gastroplasty for morbid obesity. Regul Pept 1985; 12: 231-236.
25. Druce MR, Small CJ, Bloom SR. Minireview: Gut peptides regulating satiety. Endocrinology 2004; 145: 2660-2665.
26. Reinehr T, Brylak K, Alexy U, Kersting M, Andler W. Predictors to success in outpatient training in obese children and adolescents. Int J Obes Relat Metab Disord 2003; 27: 1087-1092.
27. Reinehr T, Kersting M, Alexy U, Andler W. Long-term follow-up of overweight children: after training, after a single consultation session and without treatment. J Pediatr Gastroenterol Nutr 2003; 37: 72-74.
28. Kromeyer-Hauschild K, Wabitsch M, Geller F, Ziegler A, Geiß HC, Hesse V et al. Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 2001; 149: 807-818.
29. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990; 44: 45-60.
30. Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD et al. Skinfold equations for estimation of body fatness in children and youth. Hum Biol 1988; 60: 709-723.
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
32. Reinehr T, Kiess W, Kapellen T, Andler W. Insulin sensitivity in obese children and adolescents according to degree of weight loss. Pediatrics 2004; 114: 1569-1573.
33. Reinehr T, Andler W. Changes in the atherogenic risk-factor profile according to degree of reduction of overweight. Arch Dis Child 2004; 89: 419-422.
34. Koska J, Delparigi A, de Courten B, Weyer C, Tataranni PA. Pancreatic polypeptide is involved in the regulation of body weight in Pima Indian male subjects. Diabetes 2004; 53: 3091-3096.
35. Drent ML, Popp-Snijders C, Ader HJ, Jansen JB, van der Veen EA. Lipase inhibition and hormonal status, body composition and gastrointestinal processing of a liquid high-fat mixed meal in moderately obese subjects. Obes Res 1995; 3: 573-581.
36. Floyd JC. Human pancreatic polypeptide. J Clin Endocrinol Metab 1979; 8: 379-399.
37. Hansen BC, Jen KL, Pek SB, Wolfe RA. Fluctuations in basal plasma levels of pancreatic polypeptide in monkeys and humans. Am J Physiol 1985; 248: R739-R747.
38. Holst JJ, Schwartz TW, Lovgreen NA, Pedersen O, Beck-Nielsen H. Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity. Int J Obes Relat Metab Disord 1983; 7: 529-538.
39. Lieverse RJ, Masclee AA, Jansen JB, Lamers CB. Plasma cholecystokinin and pancreatic polypeptide secretion in response to bombesin, meal ingestion and modified sham feeding in lean and obese persons. Int J Obes Relat Metab Disord 1994; 18: 123-127.
40. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabetes Med 2002; 19: 527-534.
41. Sichert-Hellert W, Kersting M, Schöch G. Underreporting of energy intake in 1 to 18 year old German children and adolescents. Z Ernährungswiss 1998; 37: 242-251.